Skip to Main Content
Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Journal Club
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • NABP
    • Additional Requirements
    • Exemptions
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • FAQs
    • Enterprise Admin Support
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Resources

Resources

  • Diabetes (859)
  • Endocrinology (8)
  • Hyperglycemia (29)
  • Hypoglycemia (14)
  • Other (31)
  • Prediabetes (4)
  • Resources (268)
    • Charts (51)
    • Guidelines (81)
    • Letters (3)
    • Natural Medicines / Supplements (4)
    • Patient Education (12)
    • PL Voices (153)
    • Quality Measures (39)
  • Thyroid Disorders (63)
256 - 268 of 268 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: Avandia (Rosiglitazone) and the Risk of Myocardial Infarction June 2007
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) November 2006
Guideline: American Diabetes Association Position Statement on Insulin Administration (2004) September 2006
Commentary: Diabetes Peripheral Neuropathic Pain Treatment August 2006
Guideline: Consensus Guidelines: Treatment Planning and Options (2006) August 2006
Commentary: Guidelines for Self-Monitoring of Blood Glucose (SMBG) June 2004
Guideline: Canadian Diabetes Association Clinical Practice Guidelines on Monitoring Glycemic Control (2008) June 2004
Guideline: ADA Position Statement on Dyslipidemia Management in Adults with Diabetes (2004) June 2004
Guideline: American Diabetes Association Position Statement - Standards of Medical Care in Diabetes 2008 June 2004
Guideline: American College of Physicians Clinical Practice Guideline on Lipid Control in the Management of Type 2 Diabetes Mellitus (2004) June 2004
Commentary: Lipid Control in Diabetes: Review of Clinical Practice Guidelines June 2004
Commentary: Monitoring the Metabolic Effects of Atypical Antipsychotics March 2004
Guideline: 2004 Consensus Statement on Antipsychotic Drugs and Obesity and Diabetes March 2004
  • « Prev
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved